Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02493647 · ClinicalTrials.gov registry record · NA
Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk
A NA study of HIV and Sexual Behavior, sponsored by Northeastern University.
- Completed
- Registry status
- NA
- Development phase
- 814
- Enrollment target
- 1
- Study location
NCT02493647: Completed NA study of HIV and Sexual Behavior, sponsored by Northeastern University.
NCT02493647 is a NA study of HIV and Sexual Behavior that has completed, run by Northeastern University. The registered enrollment target is 814 participants, above the 437-participant average among 303 other HIV trials with a reported enrollment target (86% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02493647, a NA study of HIV and Sexual Behavior, has completed, sponsored by Northeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 814 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests a 12-episode Internet-based, guide enhanced Love, Sex, \& Choices (LSC) HIV prevention soap opera video series for smartphones or computers, in a randomized clinical trial among predominately at-risk African American urban women. The following hypotheses are to be tested: 1) The LSC treatment arm will show lower unprotected sex risk, meaning lower frequency of unprotected sex (vaginal + anal) with high risk partners at 6 months post intervention compared to an attention control arm 2) The LSC treatment arm will show higher participation in HIV testing at 6 months post intervention compared to the control. If effective, this video intervention could be rapidly implemented and brought to scale at low cost via the Internet, widely reaching young urban women with the goal of reducing HIV risk behavior and increasing HIV testing.
Primary Outcome
test hypothesis that the LSC treatment arm will show lower unprotected sex risk, meaning lower frequency of unprotected sex (vaginal + anal) with high risk partners at 6 months post intervention compared to an attention control arm
Conditions Studied
Interventions
- BEHAVIORAL Love, Sex, & Choices
Study Locations (1)
Massachusetts
- Northeastern University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 814 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-09 |
| Phase | NA |
What the finished NCT02493647 record still lists
NCT02493647 is an interventional study that assigns participants to a tested intervention. The registered 814 participants enrollment target is mid-sized for trials with a published cap, above the 437-participant average among 303 other HIV trials with a reported enrollment target (86% higher).
The record links to 5 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Love, Sex, & Choices is the first listed.
NCT02493647 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02493647 about?
NCT02493647 is a clinical study titled "Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk". This study tests a 12-episode Internet-based, guide enhanced Love, Sex, \& Choices (LSC) HIV prevention soap opera video series for smartphones or computers, in a randomized clinical trial among predominately at-risk African American urban women. The following hypotheses are to be tested: 1) The LS...
What is the current status of trial NCT02493647?
This trial is currently completed. It is a NA study. The enrollment target is 814 participants. The study started on 2015-09. Estimated completion is 2018-09.
What conditions does trial NCT02493647 study?
This clinical trial studies the following conditions: HIV, Sexual Behavior, Risk Behavior, Chlamydia, Women's Role.
What interventions are being tested in trial NCT02493647?
The interventions under investigation include: Love, Sex, & Choices (BEHAVIORAL).
Who is sponsoring clinical trial NCT02493647?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02493647 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02493647's enrollment target sits among peer trials
814 25th of 303 higher than 279 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia